Yes, IMO we will see either direct new information being reported or new plans for direct work w/FDA (or other Reg.Body) . Note the by (my read NLT) H1 2022 comments written . (he said a long time ago) A- non trivial- result NLT the end of June 2022...very direct commitment language of a type seldom seen . Unambiguos NLT, end of june 2022.
IMO, Dr.M. does not say stuff like that and then ...mail it in.
BTW, IMO AVXL have had (whatever) the required supporting evidence for a while now, just a hunch.
This is just NOT the kind of editing error I expect to see . AVXL, will deliver what they believe to be the goods on R&D day.